Another strategy is the use of molecular biology techniques, introducing the LMP2 gene into the NPC patient, expressing the endogenous LMP2 protein and activating its own specific memory CD8+ T cells. This evidence concerns the gene CD8A and nasopharyngeal carcinoma.